“⏳NO.1작대@ 텔레OT163 작업대출성공 작대성공 작대후기❤️⏳”的搜索结果，显示 131-140 项，共有 6284 项

1. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   The purpose of this study is to identify a biomarker (or biomarkers) that is present when disease is present (i.e., at diagnosis or recurrence) and not ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study includes 2 parts; step-up dose optimization (Part 1) and dose expansion (Part 2). In Part 1, different level of step-up doses are tested followed ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...

5. 外科 - 临床试验- 妙佑医疗国际

   The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment with carboplatine/vincristine (CV) for ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...

7. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide ...

8. 外科 - 临床试验- 妙佑医疗国际

   The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment with carboplatine/vincristine (CV) for ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

10. 外科 - 临床试验- 妙佑医疗国际

    The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment with carboplatine/vincristine (CV) for ...